Your browser doesn't support javascript.
loading
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.
Cameroni, Elisabetta; Bowen, John E; Rosen, Laura E; Saliba, Christian; Zepeda, Samantha K; Culap, Katja; Pinto, Dora; VanBlargan, Laura A; De Marco, Anna; di Iulio, Julia; Zatta, Fabrizia; Kaiser, Hannah; Noack, Julia; Farhat, Nisar; Czudnochowski, Nadine; Havenar-Daughton, Colin; Sprouse, Kaitlin R; Dillen, Josh R; Powell, Abigail E; Chen, Alex; Maher, Cyrus; Yin, Li; Sun, David; Soriaga, Leah; Bassi, Jessica; Silacci-Fregni, Chiara; Gustafsson, Claes; Franko, Nicholas M; Logue, Jenni; Iqbal, Najeeha Talat; Mazzitelli, Ignacio; Geffner, Jorge; Grifantini, Renata; Chu, Helen; Gori, Andrea; Riva, Agostino; Giannini, Olivier; Ceschi, Alessandro; Ferrari, Paolo; Cippà, Pietro E; Franzetti-Pellanda, Alessandra; Garzoni, Christian; Halfmann, Peter J; Kawaoka, Yoshihiro; Hebner, Christy; Purcell, Lisa A; Piccoli, Luca; Pizzuto, Matteo Samuele; Walls, Alexandra C; Diamond, Michael S.
Affiliation
  • Cameroni E; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Bowen JE; Department of Biochemistry, University of Washington, Seattle, WA, USA.
  • Rosen LE; Vir Biotechnology, San Francisco, CA, USA.
  • Saliba C; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Zepeda SK; Department of Biochemistry, University of Washington, Seattle, WA, USA.
  • Culap K; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Pinto D; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • VanBlargan LA; Department of Medicine, Washington University of School of Medicine, St Louis, MO, USA.
  • De Marco A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • di Iulio J; Vir Biotechnology, San Francisco, CA, USA.
  • Zatta F; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Kaiser H; Vir Biotechnology, San Francisco, CA, USA.
  • Noack J; Vir Biotechnology, San Francisco, CA, USA.
  • Farhat N; Vir Biotechnology, San Francisco, CA, USA.
  • Czudnochowski N; Vir Biotechnology, San Francisco, CA, USA.
  • Havenar-Daughton C; Vir Biotechnology, San Francisco, CA, USA.
  • Sprouse KR; Department of Biochemistry, University of Washington, Seattle, WA, USA.
  • Dillen JR; Vir Biotechnology, San Francisco, CA, USA.
  • Powell AE; Vir Biotechnology, San Francisco, CA, USA.
  • Chen A; Vir Biotechnology, San Francisco, CA, USA.
  • Maher C; Vir Biotechnology, San Francisco, CA, USA.
  • Yin L; Vir Biotechnology, San Francisco, CA, USA.
  • Sun D; Vir Biotechnology, San Francisco, CA, USA.
  • Soriaga L; Vir Biotechnology, San Francisco, CA, USA.
  • Bassi J; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Silacci-Fregni C; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Gustafsson C; ATUM, Newark, CA, USA.
  • Franko NM; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.
  • Logue J; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.
  • Iqbal NT; Department of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
  • Mazzitelli I; Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Geffner J; Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Grifantini R; National Institute of Molecular Genetics, Milan, Italy.
  • Chu H; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.
  • Gori A; Infectious Disease Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
  • Riva A; Department of Biomedical and Clinical Sciences 'L.Sacco' (DIBIC), Università di Milano, Milan, Italy.
  • Giannini O; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.
  • Ceschi A; Department of Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
  • Ferrari P; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.
  • Cippà PE; Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Franzetti-Pellanda A; Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Garzoni C; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland.
  • Halfmann PJ; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.
  • Kawaoka Y; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Hebner C; Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
  • Purcell LA; Department of Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
  • Piccoli L; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Pizzuto MS; Faculty of Medicine, University of Zurich, Zurich, Switzerland.
  • Walls AC; Clinical Research Unit, Clinica Luganese Moncucco, Lugano, Switzerland.
  • Diamond MS; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland.
Nature ; 602(7898): 664-670, 2022 02.
Article in En | MEDLINE | ID: mdl-35016195
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Neutralization Tests / Broadly Neutralizing Antibodies / SARS-CoV-2 / Antigenic Drift and Shift / Antibodies, Monoclonal / Antibodies, Viral Limits: Animals / Humans Language: En Journal: Nature Year: 2022 Type: Article Affiliation country: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Neutralization Tests / Broadly Neutralizing Antibodies / SARS-CoV-2 / Antigenic Drift and Shift / Antibodies, Monoclonal / Antibodies, Viral Limits: Animals / Humans Language: En Journal: Nature Year: 2022 Type: Article Affiliation country: Switzerland